At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19,894 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Observational Registry Study Focusing on the Real World Use, Effectiveness and Safety of Initial Basal Insulin Regimen in Type 2 Diabetic Patients Uncontrolled by Oral Antidiabetic Drugs in China
The George Institute for Global Health, China·observational·Posted May 22, 2013·Updated Oct 12, 2016
In Brief
An observational study for Diabetes. Completed, enrolled 19,894 participants across 2 sites.
Detailed Summary
The scientific use of basal insulin is of great help to individuals and the government. However, there are few studies to investigate the real world use, effect, safety and influence factors of basal insulin in China. This study is to evaluate the use of first basal insulin in China patients with type 2 diabetes with inadequate glycemic control on oral antidiabetic agents (OADs) from the naturalistic clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesChina
CollaboratorsChinese Diabetes Society
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2011
First PostedMay 2013
Primary CompletionJun 2014
TodayJul 2026
First PostedMay 22, 2013
Enrollment StartDec 1, 2011
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 13.1 years ago